National Institute on Aging: NIA has been a Platinum sponsor of the Vitamin D Workshops since 2014 in the form of a Scientific Meeting Grant (R13AG048689) entitled “Annual Vitamin D Workshops. Funding for this conference was made possible, in part, by R13 AG48689-01 from the National Institute on Aging. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

OPKO is a GOLD Sponsor for the 2024 Vitamin D Workshop. OPKO has been a strong supporter of the workshop for many years.  OPKO has developed RAYALDEE , an extended-release oral formulation of calcifediol which is approved by the FDA for treatment of secondary hyperparathyroidism in adults with CKD and vitamin D insufficiency. Please visit their website and network with their scientists during the meeting.

Elsevier is the publisher of the recently released (October 2023) “Feldman and Pike’s Vitamin D” a two-volume compendium covering “Biochemistry, Physiology and Diagnostics” (Volume One) and “Disease and Therapeutics” (Volume Two). Elsevier will provide a copy of the new Fifth Edition to a highly ranked abstract submitted by a Young Investigator.

HEYL Chemisch-pharmazeutische Fabrik GmbH & Co.KG is a fully independent family business, that has had its head office in Berlin since its establishment in 1926. In cooperation with our international subsidiaries, our main focus is the licensing and marketing of pharmaceuticals, as well as the sales and distribution of pharmaceutical ingredients and specialty chemicals. HEYL’s cholecalciferol containing product D3-Vicotrat, a solution for intramuscular injection, is authorized in Germany, indicated for prophylaxis of vitamin D deficiency symptoms due to malabsorption if an oral therapy is impossible or ineffective.